STAT Plus: Sarepta’s stock price plummets after an ‘erroneous’ report
It was not an executive shakeup that pummeled shares of Sarepta Therapeutics on Thursday. It was not rumors of a takeover Wall Street didn’t like.
Instead, it was a mistake.
Continue to STAT Plus to read the full story…
Read Original Article: STAT Plus: Sarepta’s stock price plummets after an ‘erroneous’ report »
